ACCENDRA HEALTH INC/VA/ ACH
NYSE · XNYS · stock · Wholesale-Medical, Dental & Hospital Equipment & Supplies
Chart by TradingView
3/9
Piotroski F — financial health
-2.59
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $2.8B | -$1.1B | — | -$292.7M | -$461.0M |
| 2024 | $2.7B | -$362.7M | $2.2B | -$8.8M | $586.4M |
| 2023 | $2.6B | -$41.3M | $2.1B | $568.3M | $945.3M |
| 2022 | $10.0B | $22.4M | $1.8B | $166.9M | $966.7M |
| 2021 | $9.8B | $221.6M | $1.5B | $83.2M | $938.5M |
| 2020 | $8.5B | $29.9M | $1.3B | $288.8M | $712.1M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.59 (distress)
- Working capital / assets -0.163
- Retained earnings / assets -0.44
- EBIT / assets 0.011
- Equity / liabilities -0.158
Source: SEC EDGAR filings · CIK 0000075252 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.